Nasal Spray Market - By Type (Steroid, Antihistamine, Decongestant, Saline), By Application (Sinusitis, Allergic Rhinitis, Nasal Polyps), By Patient (Adult, Pediatric), By Distribution Channel (Hospital, Retail, Online)- Global Forecast 2023 to 2032

Nasal Spray Market Size

Nasal Spray Market size was evaluated to be around USD 24.48 billion in 2022 and is projected to expand at over 6.7% from 2023 to 2032. The growth is attributed to factors such as the growing prevalence of chronic respiratory diseases and nasal disorders, rising demand for nasal sprays, and new nasal spray product launches for various disease treatments.
 

Nasal drug delivery is also known as snorting, in which the medications are inhaled through the nose. Nasal spray is one of the nasal drug delivery systems that helps deliver the drug directly into the nasal cavities. It has several advantages, like rapid absorption of drugs, faster onset of action, lesser degradation of drugs, and non-invasiveness. Nasal sprays are effective for treating various diseases like nasal allergies, colds, hay fever, sinusitis, non-allergic rhinitis, and nasal polyps. It facilitates in cleaning the nasal passage and mucus present due to cold.
 

COVID-19 Impact

COVID-19 has significantly impacted the growth of the nasal spray market worldwide. Due to COVID-19 symptoms such as fever, cold, cough, runny nose, and shortness of breath, there was an increased demand for nasal sprays. Factors such as ease of administration and refilling medication at home contributed to the growth of this market. Moreover, during COVID-19, pharmaceutical companies increased their R&D investments in order to develop nasal sprays for the treatment and prevention of coronavirus. In 2020, Regeneron (U.S.) announced a collaboration with scientists at the University of Pennsylvania to investigate whether technology developed for gene therapy can be used to make nasal sprays for treating coronaviruses.
 

Nasal Spray Market Trends

Increasing chronic respiratory diseases and nasal disorders will help the global nasal spray market showcase massive progress. It is most commonly used to treat sinusitis, nasal polyps, nasal congestion, and allergic rhinitis. Nasal sprays can be used for sinusitis to reduce inflammation and nasal congestion. Due to advantages like easy and fast administration of drugs, drug delivery to localised parts, non-invasiveness, and patient convenience, the demand for nasal sprays is high. With the increasing prevalence of nasal disorders, significant growth will be witnessed over the forecast period.
 

Owing to the advantages of nasal spray, pharmaceutical and biotechnology companies have increased their investment in R&D in order to develop new nasal spray products to treat various diseases like coronaviruses or CNS disorders. For instance, in March 2023, Pfizer got approval from the FDA for a Zavzpret which is a nasal spray used for the treatment of migraines. In March 2019, Janssen Pharmaceutical’s Spravato (esketamine) got FDA approval, which is a nasal spray used by adult patients with treatment-resistant depression.
 

Thus, pharmaceutical companies have increased research activities for the development of new nasal spray products to treat different diseases. The improved healthcare infrastructure, increasing healthcare expenditures, and R&D funding will propel the market landscape.
 

Nasal Spray Market Analysis

Based on type, the nasal spray market is subdivided into steroids, antihistamines, decongestants, saline solutions, and other types. The steroid segment dominated the market in 2022 with a revenue share of 31.8% and is expected to witness massive growth at the highest CAGR. The steroid nasal sprays are used in the treatment of sinusitis, allergic rhinitis, and nasal polyps. They help to decrease nasal inflammation, mucus production, and nasal congestion, improving sinus drainage. After from these, commercialization of cost-effective generic steroid sprays and their easy availability drives the market grow.
 

Based on applications, the nasal spray market is classified into sinusitis, allergic rhinitis, nasal polyps, and other applications. The sinusitis segment accounted for the largest share in 2022 due to the high prevalence of sinusitis. During the forecast period, the nasal polyps segment is estimated to grow at a higher rate due to the increasing cases of nasal polyps and nasal polys is occurs mostly in the patients with asthma, sinusitis and allergic rhinitis. Nasal sprays help reduce swelling and can shrink the polyps or eliminate them. The increased demand for nasal sprays as an effective treatment option for treating diseases will boost this market size.
 

Based on patient type, the global nasal spray market is subdivided into adults, pediatrics, and infants. Among the patient type segments, the adults segment held the highest revenue share of the market in 2022 With the high prevalence of diseases like sinusitis occurring in patients over 45 and the increasing geriatric population as they are more susceptible to nasal allergies and respiratory diseases, the growth of the nasal spray market will escalate.
 

Based on distribution channel, the global nasal spray market is segmented into retail, hospital, and online pharmacies. In 2022, the market was predominantly driven by the retail pharmacies segment. Due to the increasing prevalence of chronic respiratory disorders and nasal diseases, awareness and utilization of nasal sprays to treat conditions like runny nose, nasal congestion, swelling, and many others will help the market grow. Some of the nasal sprays do not require a prescription and can be sold over the counter, increasing the demand and utilization of nasal sprays in retail pharmacy stores.
 

In 2022, the North America held the highest revenue in this market, owing to an increased prevalence of diseases like sinusitis, allergic rhinitis, nasal polyps, cold, and other respiratory diseases, increasing investments for R&D for developing nasal sprays for treating various diseases, presence of key players, and increased healthcare expenditure are the factors contributing the growth of this segment. U.S. accounted for the highest market share in 2022 due to the increasing number of product launches, acquisitions and increasing awareness and demand for nasal sprays.
 

Nasal Spray Market Share

The key players in nasal spray market are:

• Bayer AG
• Novartis AG
• GlaxoSmithKline plc
• ADAPt Pharma Inc
• Cipla Inc
• AbbVie Inc
• Aurena Laboratories
• Sun Pharmaceutical Industries Ltd
• Viatris Inc and Leeford Healthcare Limited.
   

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches, etc. to maintain a competitive edge in the industry.
 

Nasal Spray Industry News:

• In March 2023, Pfizer’s Zavzpret got FDA approval, which is a nasal spray used for the treatment of migraine.
   
• In March 2019, Janssen Pharmaceutical’s Spravato (esketamine) got FDA approval, which is a nasal spray used by adult patients with treatment-resistant depression.
   

The nasal spray market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type

• Steroids
• Antihistamine
• Decongestants
• Saline solutions
• Other types

By Application

• Sinusitis
• Allergic rhinitis
• Nasal polyps
• Other applications

By Patient Type

• Adults
• Pediatrics
• Infants

By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Switzerland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA